BCG mediated protection of the lung against experimental SARS-CoV-2 infection

The observation of reduced COVID-19 incidence and severity in populations receiving neonatal intradermal BCG vaccination vaccine raised the question of whether BCG can induce non-specific protection against the SARS-CoV-2 (SCV2) virus. Subsequent epidemiologic studies and clinical trials have largel...

Descripción completa

Detalles Bibliográficos
Autores principales: Hilligan, Kerry L., Namasivayam, Sivaranjani, Sher, Alan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514903/
https://www.ncbi.nlm.nih.gov/pubmed/37744331
http://dx.doi.org/10.3389/fimmu.2023.1232764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514903/
https://www.ncbi.nlm.nih.gov/pubmed/37744331
http://dx.doi.org/10.3389/fimmu.2023.1232764

Ejemplares similares